223 reports of this reaction
3.1% of all DOXYLAMINE SUCCINATE reports
#3 most reported adverse reaction
FATIGUE is the #3 most commonly reported adverse reaction for DOXYLAMINE SUCCINATE, manufactured by Chattem, Inc.. There are 223 FDA adverse event reports linking DOXYLAMINE SUCCINATE to FATIGUE. This represents approximately 3.1% of all 7,212 adverse event reports for this drug.
Patients taking DOXYLAMINE SUCCINATE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among DOXYLAMINE SUCCINATE users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for DOXYLAMINE SUCCINATE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 223 FDA reports for DOXYLAMINE SUCCINATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.1% of all adverse event reports for DOXYLAMINE SUCCINATE, making it one of the most commonly reported side effect.
If you experience fatigue while taking DOXYLAMINE SUCCINATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.